Immune regulator

The term Immune regulator refers to a broad and heterogeneous class of molecules that modulate the activity, intensity, and duration of the immune response. This category includes a wide array of proteins such as cytokines, chemokines, and immune checkpoint receptors (e.g., PD-1, CTLA-4) that act as brakes or accelerators for the immune system (Source: National Cancer Institute). Because the term describes a functional role rather than a specific molecular entity, it is not a single therapeutic target but rather a classification for various targets involved in immune homeostasis. In the context of disease, immune regulators are often dysregulated; for instance, cancer cells may exploit inhibitory regulators to evade detection, while overactive regulators can lead to autoimmune disorders (Source: Nature Reviews Immunology). Therapeutic intervention involves using agonists or antagonists to either stimulate the immune system to fight pathogens and tumors or suppress it to treat inflammation and transplant rejection. Consequently, while the concept of immune regulation is central to modern pharmacology, Immune regulator itself is a functional category rather than a specific druggable molecule.

Other names

ImmunomodulatorImmune system modulatorBiological response modifier

Mechanisms of action vary significantly across the class, including the blockade of inhibitory checkpoint receptors (e.g., PD-1/PD-L1), the neutralization of pro-inflammatory cytokines (e.g., TNF-alpha), or the activation of stimulatory pathways to enhance anti-tumor immunity.